Precision Oncology & Functional Precision Medicine
Collaboration across patient-derived models, drug-response profiling, precision oncology and international technology development.
Precision OncologyPatient-Derived ModelsTechnology Translation
Loading video...
From Discovery to Real-World Impact
Integrated biotechnology development from translational research to product development and production.
InnovationBeyondBoundaries
20+
Development Programs
8+
Industry & Clinical Collaborations
5+
International Collaborations
6
Core Development Platforms
Scroll to Explore
Our Ecosystem
One Ecosystem, Infinite Possibilities
01
Discovery & Translational Biology
From biological mechanisms and molecular targets to translational experimental models.
02
Molecular & Biomarker Intelligence
Integrated molecular profiling and biomarker strategies for deeper biological insight.
03
Product & Formulation Development
From formulation concepts and biomaterials to functional validation and product-ready evidence.
04
Biologics, Peptides & Biotechnology Raw Materials
Development of peptide, recombinant and biotechnology-derived products and intermediates.
05
Preclinical Development & Validation
In vitro, ex vivo and in vivo programs designed to evaluate efficacy, safety and biological performance.
06
Precision Oncology & Clinical Translation
Patient-derived models, precision medicine and biomarker-driven research for clinically relevant development.
01
Discovery & Translational Biology
From biological mechanisms and molecular targets to translational experimental models.
02
Molecular & Biomarker Intelligence
Integrated molecular profiling and biomarker strategies for deeper biological insight.
03
Product & Formulation Development
From formulation concepts and biomaterials to functional validation and product-ready evidence.
04
Biologics, Peptides & Biotechnology Raw Materials
Development of peptide, recombinant and biotechnology-derived products and intermediates.
05
Preclinical Development & Validation
In vitro, ex vivo and in vivo programs designed to evaluate efficacy, safety and biological performance.
06
Precision Oncology & Clinical Translation
Patient-derived models, precision medicine and biomarker-driven research for clinically relevant development.
Our Ecosystem
Explore Our
Capabilities
Integrated scientific and development capabilities spanning discovery, validation, product development and clinical translation.
We develop biologically relevant experimental systems that connect fundamental mechanisms with translational research and downstream development.
Selected Project Portfolio
27 programmes
From Mechanism to Translation
Selected programs spanning precision oncology, preclinical development, neuroimmune biology, product innovation and biotechnology raw materials.
Filters
Selected Partnerships
Built Together.
Built to Translate.
We collaborate with technology, industry and innovation partners to turn scientific progress into real-world solutions.
Integrated R&D, Clinical Development & Product Innovation
Strategic collaboration spanning product development, preclinical and clinical research, biological validation and industry translation.
Product DevelopmentPreclinical ResearchClinical ResearchIndustry Translation
Biotechnology Infrastructure & Innovation Ecosystem
An innovation environment supporting biotechnology development, entrepreneurship, infrastructure access and collaborative R&D.
Innovation EcosystemR&D InfrastructureTechnology Development
Interested in partnering with Imperion?Discuss a Collaboration→
Insights & News
News from
Our Lab
The talks, partnerships and science behind our work.
On stage and in the field — international conferences, congresses and invited lectures.
Oral Presentation2026
EPC / IAP Joint Meeting 2026 — Istanbul
Best Abstracts Session
Our work on NMDAR1A- and IL-10-centered neuroimmune targeting in chronic pancreatitis has been selected for oral presentation in the Best Abstracts · Chronic Pancreatitis session at the EPC / IAP Joint Meeting 2026 in Istanbul.
Read full page→Oral LectureJuly 2025
57th European Pancreatic Club — Düsseldorf
Chronic Pancreatitis · Pain Biology
An oral lecture on targeting NMDA Receptor 1A to ameliorate pain in chronic pancreatitis, marking a major milestone after three consecutive years of EPC visibility.
Read full page→Oral Presentation2024
56th European Pancreatic Club — Santiago de Compostela
Neuroimmune Targeting · Monoclonal Antibody
A hybridoma-derived CX3CR1-targeting monoclonal antibody strategy was presented as an oral presentation, highlighting neuroimmune pain modulation in pancreatic disease.
Read full page→Oral Presentation2025
EFIS Oral Presentation — CX3CR1 Antibody Development
Neuroimmune Targeting · Monoclonal Antibody
A hybridoma-derived CX3CR1-targeting monoclonal antibody strategy was presented as an oral presentation at the European Federation of Immunological Societies, highlighting neuroimmune pain modulation in pancreatic disease.
Read full page→Poster · Travel Grant2026
Pancreatic Cancer Conference 2026 — London
Flash Talk Under Review
Our study on the transition from chronic pancreatitis to pancreatic cancer was accepted for poster presentation with travel grant support, focusing on TG2 fibrosis, senescence and neuroimmune pain.
Read full page→Poster · Travel Grant2025
EACR Cancer Neuroscience — Bilbao
Nerve–Tumour–Immune Crosstalk
Our poster explored how NMDA receptor signalling may shape the dialogue between nerves, tumour cells and immune cells in pancreatic cancer and chronic pancreatitis.
Read full page→Recognition2026
EACR Ambassador Role
European Association for Cancer Research
Imperion co-founders Deniz Baybağ and Nedim Can Çevik were selected as EACR Ambassadors, supporting the visibility of cancer research opportunities and scientific networks across Europe.
Read full page→Guest Speaker2026
geneXplore Program
Featured Alongside Leading Industry Names
Imperion Biotechnology joined geneXplore as a featured participant alongside major names including AstraZeneca, Novartis, Atabay Biotechnology and Nobel İlaç.
Read full page→Guest Lecture2026
University Guest Speaker Sessions
Students · Researchers · Translational Biotechnology
Imperion co-founders were invited to share the company’s story, scientific direction and translational biotechnology vision with students and young researchers.
Read full page→FAQ
Questions
Before We Start
A few things to know about working with Imperion.
We can contribute from early scientific concept and model development through preclinical validation, clinical translation, product development and scale-up planning. Our role is defined according to the current stage and development needs of each program.
Have a different question?
We're happy to discuss your needs.
Let's Work Together
Ready to Advance
Your Project?
Tell us where your program stands and where it needs to go. We'll help define the most effective development pathway.